GNFT logo

GENFIT S.A. American Depositary Shares

GNFT

GNFT: Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. The company conducts clinical trials in a variety of European and North American countries when advancing through stages of development. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

more

Show GNFT Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of GNFT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by GNFT's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard
Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Automated pattern recognition and scoring method of histological images Jun. 13, 2023
  • Patent Title: Pharmaceutical compositions for combination therapy Feb. 28, 2023
  • Patent Title: Non-invasive diagnostic of non-alcoholic fatty liver diseases, non-alcoholic steatohepatitis and/or liver fibrosis Dec. 06, 2022
  • Patent Title: Combination comprising a ppar agonist such as elafibranor and an acetyl-coa carboxylase (acc) inhibitor Nov. 01, 2022
  • Patent Title: Combination of elafibranor or derivatives thereof with an anti-nash, anti-fibrotic or anti-cholestatic agent Oct. 25, 2022
  • Patent Title: Methods of treatment for cholestatic and fibrotic diseases Aug. 02, 2022
  • Patent Title: Methods for diagnosing and evaluating non-alcoholic steatohepatitis Jun. 28, 2022
  • Patent Title: Methods of treatment of cholestatic diseases May. 17, 2022
  • Patent Title: Pharmaceutical compositions for combination therapy Dec. 07, 2021
  • Patent Title: Methods of treatment of cholestatic diseases Nov. 30, 2021
  • Patent Title: Rorgamma modulators and uses thereof Nov. 02, 2021
  • Patent Title: Methods of treatment for cholestatic and fibrotic diseases Aug. 31, 2021
  • Patent Title: Rorgamma modulators and uses thereof Aug. 03, 2021
  • Patent Title: N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2h-1,4-benzoxazin-7-yl)acetamide derivatives and related compounds as ror-gamma modulators for treating autoimmune diseases Jul. 06, 2021
  • Patent Title: Pharmaceutical compositions for combination therapy Jun. 15, 2021
  • Patent Title: Rorgamma modulators and uses thereof Apr. 27, 2021
  • Patent Title: Methods of treatment for cholestatic and fibrotic diseases Feb. 02, 2021
  • Patent Title: Derivatives of 6-substituted triazolopyridazines as rev-erb agonists Oct. 13, 2020
  • Patent Title: Methods of treatment of fibrosis and cancers Oct. 06, 2020
  • Patent Title: Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Jul. 28, 2020
  • Patent Title: Methods of treatment for cholestatic and fibrotic diseases May. 19, 2020
  • Patent Title: Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Jul. 16, 2019
  • Patent Title: Methods of treatment for cholestatic and fibrotic diseases Nov. 20, 2018
  • Patent Title: Methods of treatment for cholestatic and fibrotic diseases Nov. 20, 2018
  • Patent Title: Methods of treatment for cholestatic and fibrotic diseases Nov. 06, 2018
  • Patent Title: Methods of treatment for cholestatic and fibrotic diseases Nov. 06, 2018
  • Patent Title: Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Jul. 17, 2018
  • Patent Title: Heterocyclic derivatives as rorgamma modulators Feb. 27, 2018
  • Patent Title: Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Oct. 10, 2017
  • Patent Title: Derivatives of 6-substituted triazolopyridazines as rev-erb agonists Mar. 07, 2017
  • Patent Title: Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Mar. 07, 2017
  • Patent Title: Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Dec. 29, 2015
  • Patent Title: 1,3-diphenylpropane derivatives, preparations and uses thereof Aug. 25, 2015
  • Patent Title: Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Nov. 25, 2014
  • Patent Title: Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Jul. 08, 2014
  • Patent Title: Preparation of chalcone derivatives Jul. 01, 2014
  • Patent Title: Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof Jun. 11, 2013
  • Patent Title: Ppar agonist compounds, preparation and uses Jun. 11, 2013
  • Patent Title: Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof Sep. 04, 2012
  • Patent Title: Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof May. 29, 2012
  • Patent Title: Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof Jan. 31, 2012
  • Patent Title: Substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof Nov. 15, 2011
  • Patent Title: Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof May. 17, 2011
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of GNFT in WallStreetBets Daily Discussion

GNFT News

Recent insights relating to GNFT

CNBC Recommendations

Recent picks made for GNFT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GNFT

Corporate Flights

Flights by private jets registered to GNFT